ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Celecoxib

Also written as “celecoxib”, “Celecoxib 200mg” and “Celecoxib + Acetaminophen”.

Its studies are mostly in Osteoarthritis · Osteoarthritis, Knee · Low Back Pain · Migraine Disorders · Pain, Postoperative, led by 16 companies.

Drug pageCelecoxib: every studyMany companies study it; this page follows only the 66 they lead. All 383 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Aug 26, 200566 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Viatris320 open or runningphase 4since Aug 26, 2005Aug 26, 2005none ahead
Pfizerits history only100 open or runningphase 4since Sep 9, 2005May 8, 2002none ahead
Dr. Reddy's Laboratoriesits history only40 open or runningphase 2since Jun 8, 2015Jun 8, 2015none ahead
NeuroSense Therapeuticsits history only40 open or runningphase 2since Nov 13, 2019Aug 29, 2019none ahead
Leidos Life Sciencesits history only30 open or runningphase 2since Oct 7, 2021Oct 7, 2021none ahead
BioDelivery Sciences Internationalits history only20 open or runningphase 3since Dec 27, 2016Dec 27, 2016none ahead
Laboratorios Silanes S.A. de C.V.its history only20 open or runningphase 3since Jun 26, 2024Jun 26, 2024none ahead
Aralez Pharmaceuticalsits history only10 open or runningphase 1since Aug 5, 2008Aug 5, 2008none ahead
Arthritis Innovationits history only10 open or runningphase 2since May 8, 2018May 8, 2018none ahead
Astellas Pharmaits history only10 open or runningphase 3since May 5, 2010May 5, 2010none ahead

Also a collaborator on its studies: AstraZeneca.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Viatris only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 11 studies since Aug 26, 2005.

  1. Nov 21, 2006Phase 3 study in PharyngitisNCT00402987 · 269 enrolled · United States
  2. Mar 9, 2007Phase 4 study in Ankle InjuriesNCT00446797 · 278 enrolled · Brazil, Costa Rica, Ecuador and more
  3. Oct 24, 2007Phase 3 study in Arthritis, GoutyNCT00549549 · 402 enrolled · United States, Canada, Colombia and more
  4. Dec 6, 2007Phase 3 study in Low Back PainNCT00662558 · 802 enrolled · United States
  5. Jan 1, 2008Phase 3 study in Adenomatous Polyposis ColiNCT00585312 · 106 enrolled · United States, Belgium, Czechia and more
  6. Feb 12, 20082 phase 4 studies in Osteoarthritis, KneeNCT00620867, NCT00630929
  7. Mar 4, 20087 phase 4 studiesNCT00633438, NCT00633386, NCT00638807 and 4 more
  8. Sep 29, 2008Phase 3 study in Spondylitis, AnkylosingNCT00762463 · 240 enrolled · China
  9. Dec 10, 2008Phase 4 study in Arthritis, JuvenileNCT00807846 · 201 enrolled · United States, Chile, Costa Rica and more
  10. Mar 27, 2009Phase 4 study in PainNCT00894790 · 8 enrolled · Mexico
  11. Sep 11, 2009Phase 3 study in PainNCT00976716 · 80 enrolled · Japan
  12. Oct 13, 2009Phase 4 study in Healthy VolunteersNCT00994461 · 190 enrolled · Japan
  13. Feb 2, 2010Phase 2 study in PainNCT01062113 · 255 enrolled · Japan
  14. Apr 15, 2013Phase 4 study in Chronic Low Back Pain With a Neuropathic ComponentNCT01838044 · 180 enrolled · Brazil, Chile, Colombia and more

TargetBeta

PTGS2 →read by rule
“Cyclooxygenase-2 inhibitor”ChEMBL 37, by rule

Other programs on PTGS2

ProgramCompanyFurthest phaseStudies
AcetaminophenruleJohnson & Johnsonphase 4136
IbuprofenrulePfizerphase 4113
AspirinruleBayerphase 484
MeloxicamruleBoehringer Ingelheimphase 467
EtoricoxibruleOrganonphase 435
dexketoprofenruleMenarini Groupphase 48
SulfasalazineruleBristol-Myers Squibbphase 47
dexibuprofenruleaponia-laboratories-incphase 46
BenzydamineruleAngelini Pharmaphase 44
DipyroneruleHypera Pharmaphase 44
PiroxicamruleTaisho Pharmaceuticalphase 44
FlurbiprofenruleGlaxoSmithKlinephase 312

Studies

All 32 Viatris leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01838044Chronic Low Back Pain With a Neuropathic Component · Brazil, Chile, Colombia and more4TerminatedMay 2015180
NCT01062113Pain · Japan2CompletedAug 2010255
NCT00994461Healthy Volunteers · Japan4CompletedApr 2010190
NCT00976716Pain · Japan3CompletedNov 200980
NCT00894790Pain · Mexico4TerminatedJan 20108
NCT00807846Arthritis, Juvenile · United States, Chile, Costa Rica and more4CompletedDec 2012201
NCT00762463Spondylitis, Ankylosing · China3CompletedJun 2010240
NCT00643799Osteoarthritis, Knee · United States4CompletedJan 2005586
NCT00640809Inflammatory Bowel Diseases · United States4Completed408
NCT00640627Osteoarthritis, Knee · United States4Completed380
NCT00640432Low Back Pain · Brazil4Completed244
NCT00638807Osteoarthritis, Knee · United States4Completed388
NCT00633438Arthroscopy · United States4Completed204
NCT00633386Arthroscopy · United States4Completed200
NCT00630929Osteoarthritis, Knee · Germany, Spain, United Kingdom4Completed388
NCT00620867Osteoarthritis, Knee · United States4CompletedMar 2003393
NCT00585312Adenomatous Polyposis Coli · United States, Belgium, Czechia and more3TerminatedOct 2013106
NCT00662558Low Back Pain · United States3CompletedSep 2008802
NCT00549549Arthritis, Gouty · United States, Canada, Colombia and more3CompletedDec 2009402
NCT00446797Ankle Injuries · Brazil, Costa Rica, Ecuador and more4CompletedApr 2008278
NCT00402987Pharyngitis · United States3CompletedNov 15, 2007269
NCT00373685Osteoarthritis · United States, Puerto Rico4CompletedNov 20108,067
NCT00359151Osteoarthritis · United States4Terminated22
NCT00346216Arthritis, Rheumatoid · United States, Australia, Brazil and more4CompletedApr 12, 201624,081
NCT00296127Healthy Volunteers · United States1Completed24
NCT00290901Back Pain · United States, Puerto Rico4CompletedDec 2006754
NCT00163241Osteoarthritis · Canada, France3Terminated666
NCT00150280Pain, Postoperative · China3Completed132
NCT00141154Low Back Pain · Japan3Completed1,234
NCT00141102Osteoarthritis · Belgium, Brazil, Canada and more4CompletedMay 20094,484
NCT00139776Osteoarthritis, Knee · United States, Belgium, Brazil and more4CompletedFeb 2008875
NCT00137033Peptic Ulcer · United States4Completed605

How it is read

Names in the registry

  • “Celecoxib”, 49 entries
  • “celecoxib”, 7 entries
  • “Celecoxib 200mg”, 3 entries
  • “Celecoxib + Acetaminophen”, 2 entries
  • “Comparator: celecoxib”, 2 entries

Codes read as this program: DFN15.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.